Olympus Selected for two consecutive years as a Supplier Engagement Leader 2022, the Highest Rating in the CDP Supplier Engagement Rating

March 29, 2023

TOKYO, March 15, 2023 – Olympus Corporation (Olympus), a global medtech company committed to making people’s lives healthier, safer, and more filling, has been selected for two consecutive years by the CDP*1, an international non-profit organization, as a CDP 2022 Supplier Engagement Leader, the highest rating awarded under the Supplier Engagement Rating (SER).

SER evaluates how effectively companies work with their suppliers on addressing climate change issues. Companies receiving the highest rating are awarded as Supplier Engagement Leaders. In fiscal year 2022, the top 8% of respondents, or approximately 650 companies worldwide, including 131 Japanese companies, were selected as Supplier Engagement Leaders.

Olympus has specified carbon neutrality and enabling a circular economy as one of materiality items to be addressed, and has established a target of achieving carbon neutrality by 2030 with net-zero CO2 emissions from its site operations (Scope 1 and 2*2). For this purpose, we are engaged in manufacturing improvement activities, energy conservation measures, renewable energy introduction, and other initiatives. In addition, Olympus monitors and calculates greenhouse gas emissions generated at the raw material procurement, distribution, product use and other stages (Scope 3*2) for each category. We are also working to reduce greenhouse gas emissions throughout the supply chain by promoting green procurement, improving logistics efficiency and developing environmentally conscious products. Our selection as a Supplier Engagement Leader was made in recognition of these ongoing efforts.

Olympus regards Our Purpose of “Making people’s lives healthier, safer and more fulfilling” as the fundamental philosophy behind all our activities. Under this fundamental philosophy, we honor the safety and health of people, as well as the workings of nature that support these, and strive to find a balance between harmony with the environment and the economy within all our products, services and business activities, thereby contributing to the realization of a sustainable society and a healthy environment.

*1 CDP is an international non-profit organization founded in the United Kingdom in 2000. CDP collects, analyzes and evaluates information on the environmental activities of major companies around the world, and discloses the results of these to institutional investors. In fiscal year 2022, more than 680 institutional investors with a total of US$130 trillion in assets under management and 280 purchasing organizations with a total of US$6.4 trillion in funding endorsed the CDP’s activities.

*2 Scope 1: Direct greenhouse gas emissions by combustion of fuels in our sites
Scope 2: Indirect emissions from our sites use of electricity, heat or steam supplied by other companies
Scope 3: Other indirect greenhouse gas emissions (excluding Scope 1 and Scope 2)

* Products or devices presented include future technology which may be pending regional regulatory approval and are not available for sale in all regions.

* The contents in this website including products availability, specifications or prices are the information as of the date of announcement and are subject to change without prior notice.

* Information is intended to be presented to the media, shareholders, investors, and other interested parties. Information about our medical products (including products currently under development) included in this website is not intended for advertising or medical advice.

* Olympus Corporation assumes no responsibility for any damage resulting from the use of this material.

* All company names and product names mentioned in this website are trademarks or registered trademarks of their respective companies. ® and TM marks are not specified in this website. All trademarks and registered trademarks are the property of their respective owners.